How is the Astria Therapeutics Inc today?

The Astria Therapeutics Inc today is trading in the down by -1.14% at 5.22.

How has Astria Therapeutics Inc performed historically?

The Astria Therapeutics Inc is currently trading down -1.14% on an intraday basis in the past week the index rose 19.45%. The index has been down -15.94% in the past quarter and fell -41.61% in the past year. You can view this in the overview section.

What is Astria Therapeutics Inc Annual Net Profit?

Astria Therapeutics Inc Annual Net Profit fell 29.32% in the last year to $94.26 M. Its sector's average net profit growth for the last fiscal year was -13.86%.

What is Astria Therapeutics Inc Price to Earning Ratio?

Astria Therapeutics Inc Price to Earning Ratio is -2.73, which is negative.

What is Astria Therapeutics Inc Stock Price?

Astria Therapeutics Inc Stock Price fell 41.61% and underperformed its sector by 68.66% in the past year.

What is Astria Therapeutics Inc Quarterly Net profit?

Astria Therapeutics Inc Quarterly Net profit fell 69.15% YoY to $33.71 M. Its sector's average net profit growth YoY for the quarter was -238.4%.

What is Astria Therapeutics Inc Debt to Equity Ratio?

Astria Therapeutics Inc Debt to Equity Ratio of 0.02 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

What is Astria Therapeutics Inc Return on Equity(ROE)?

Astria Therapeutics Inc Return on Equity(ROE) for the last financial year was -50.71%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is Astria Therapeutics Inc Mutual Fund Holding?

Astria Therapeutics Inc Mutual Fund Holding decreased by 1.35% in the last quarter to 36.14.

What is Astria Therapeutics Inc Promoter Share Holding?

Astria Therapeutics Inc Promoter Share Holding stayed the same in the most recent quarter at 0.73%.

What is Astria Therapeutics Inc Institutional Holding?

Astria Therapeutics Inc Institutional Holding decreased by 0.59% in the last quarter to 103.34.

Astria Therapeutics Inc XNAS: ATXS

Astria Therapeutics Inc Live Share Price Today, Share Analysis and Chart

Name: Astria Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Astria Therapeutics Inc
Rating: 1.25075
Author: Trendlyne DVM scores

about

Astria Therapeutics Inc is a biopharmaceutical company engaged to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Its program, STAR-0215, is a monoclonal antibody inhibitor of pla...

5.22 -0.06 (-1.14%)

59.47% Fall from 52W High

14,536 XNAS Volume

XNAS 05 Jun, 2025 9:43 AM (EDT)

Board Meeting

The next board meeting for Astria Therapeutics Inc is on 11 Jun 2025 for the purpose of Astria Therapeutics Inc Annual General Meeting for 2025 See details

Not Eligible

Expensive Valuation

9.5 / 100

Technically Neutral

40.5 / 100

No estimates available

Astria Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Astria Therapeutics Inc Live Share Price Today, Share Analysis and Chart

Astria Therapeutics Inc is a biopharmaceutical company engaged to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Its program, STAR-0215, is a monoclonal antibody inhibitor of pla...

59.47% Fall from 52W High

SWOT Analysis

Astria Therapeutics Inc Live Price Chart

Astria Therapeutics Inc FAQ

How is Astria Therapeutics Inc today?

Astria Therapeutics Inc today is trading in the red, and is down by -1.14% at 5.22.

How has Astria Therapeutics Inc performed historically?

Astria Therapeutics Inc is currently trading down -1.14% on an intraday basis. In the past week the stock rose 19.45%. stock has been down -15.94% in the past quarter and fell -41.61% in the past year. You can view this in the overview section.